Skip to main content
A

Alytix

Alytix develops natural compound-based treatments and microbial solutions to enhance livestock health and productivity while reducing reliance on traditional antibiotics. The company targets antibiotic resistance in agriculture by providing effective alternatives that improve animal welfare and farm efficiency.

Ide, ArgentinaFounded 20182500+ followers
Updated 4 months ago

Funding

$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

The overuse of traditional antimicrobials in livestock farming has led to a rise in multi-drug resistant bacteria, creating a significant threat to animal and human health, as well as the environment. Current methods for preventing and treating bacterial infections in livestock are becoming less effective, necessitating the development of novel approaches.

Solution

Alytix develops bacteriophage-based solutions for the prevention and treatment of bacterial infections in the agricultural sector, specifically targeting the poultry, swine, and cattle industries. By combining microbiological, genomic, and bioinformatic tools, Alytix creates specific and sustainable alternatives to traditional antibiotics. Their technology platform uses microbial metagenomic diagnostics and AI-driven phage-cocktail design to address existing and emerging bacterial threats in animal health. Bacteriophages, which are viruses that specifically target and kill bacteria, offer a safe and ecologically friendly approach to combating infectious diseases and reducing the reliance on antibiotics.

Target Audience

Alytix's primary customers are livestock farmers, veterinarians, and producers in the poultry, swine, and cattle industries seeking to prevent and treat bacterial infections while reducing their dependence on traditional antibiotics.

Features

  • Bacteriophage-based solutions for targeted bacterial control
  • AI-driven phage-cocktail design for optimized efficacy
  • Products targeting E. coli, Salmonella spp., and S. aureus infections
  • Solutions for infectious diarrhea in calves, bovine mastitis, diarrhea in pigs, and salmonella in poultry
  • Sustainable and ecologically friendly alternatives to traditional antibiotics
  • Metagenomic diagnostic platform for microbial analysis
This profile is AI-generated and may contain inaccuracies.